Clinical Study on Calcarea carbonica 30C in Osteoarthritis of Knee Joint

A clinical study to evaluate the effect of Calcarea carbonica 30C in Osteoarthritis of Knee by estimating the level of serum Hyaluronan Synthase - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/06/088192

Enrollment

Registered

2025-06-04

Start date

Unknown

Completion date

Unknown

Last updated

2025-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M170- Bilateral primary osteoarthritis of knee

Interventions

Intervention1: Homoeopathic medicine: Homoeopathic medicine will be given based on the symptomatology of patients. Calacrea carbonica 30C potency administered orally daily dose on morning up to treatm

Eligibility

Inclusion criteria

Inclusion criteria: Patients with Osteoarthritis of Knee Patients with symptoms of Calcarea carbonica especially in osteoarthritis of knee and general symptoms. Sex- Both males and female Patients are willing to take only homoeopathic medicines.

Exclusion criteria

Exclusion criteria: Patients with any other seronegative arthritis. Patients with severe structural deformities and other systemic complications. Patients age below 45 and above 75 years. Patient symptoms not indicated with Calcarea carbonica.

Design outcomes

Primary

Measure	Time frame
Alteration in the serum hyaluronan synthase level. Changes in Knee Injury and Osteoarthritis Outcome Score(KOOS) values of patient. Timepoint: 6 months	—

Secondary

Measure	Time frame
Quality of Life improvedTimepoint: 6 months	—

Countries

India

Contacts

Public ContactDr.Winston Vargheese.V

Sarada Krishna Homoeopathic Medical College

drcrkrishnakumari@gmail.com9446615950

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026